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ABSTRACT: A synthetic strategy to access the fused 6–7–6 tricyclic core of hetisine-type C20-diterpenoid alkaloids is reported. This 
strategy employs a Diels–Alder cycloaddition to assemble a fused bicyclic anhydride intermediate, which is elaborated to a vinyl 
lactone-acetal bearing an aromatic ring in 5 steps. Aromatic iodination is followed by magnesium-halogen exchange with a trialkyl 
magnesiate species, which undergoes intramolecular cyclization. Subsequent oxidation provides the desired 6–7–6 tricyclic diketoal-
dehyde, with carbonyl groups at all three positions for eventual C–N bond formation and subsequent elaboration.
Diterpenoid alkaloid natural products have emerged as attrac-
tive synthetic targets by virtue of their complex caged skeletons 
and intriguing biological interactions, particularly with voltage-
gated ion channels.1 Among the many structural classifications 
that have been established, the hetisine-type C20-diterpenoid al-
kaloids have emerged as compounds of particular interest. They 
possess one of the most complex frameworks of any of the 
diterpenoid alkaloids, with a tertiary amine embedded in a 
caged heptacyclic core (see nominine (1), Figure 1), and are one 
of the most prominent diterpenoid alkaloid types, with over 120 
known members.2 Furthermore, the hetisine-type alkaloid guan-
fu base A (3, Scheme 1) is currently in clinical use in China for 
the treatment of arrhythmia,3 highlighting the therapeutic poten-
tial of these natural products. The observed biological effects of 
guan-fu base A and many other diterpenoid alkaloid natural 
products are believed to arise from their interactions with volt-
age-gated ion channels, which are emerging as important ther-
apeutic targets.4 
Figure 1. Hetisine- and Hetidine-type Diterpenoid Alkaloids. 
To date, only a single hetisine-type diterpenoid alkaloid nat-
ural product has succumbed to total synthesis: the mono-hy-
droxylated alkaloid nominine (1, Figure 1). This molecule was 
first synthesized by Natsume and Muratake in 20045 and again 
by Gin in 2006.6 Despite these initial successes, the synthesis of 
more highly-oxygenated hetisine-type alkaloids remains elu-
sive, and new strategies to access these secondary metabolites 
with suitable functional group handles are required. The synthe-
sis of the related hetidine-type core, which lacks the N–C6 bond 
(Figure 1), has seen more recent success, with routes from our 
group7 as well as the labs of Baran8 and Qin.9 While early work 
by Okamoto suggested a final N–C6 bond could be formed at a 
late stage through HLF-type chemistry,10 this transformation 
has not been successfully realized by other investigators, sug-
gesting the need for novel strategies that incorporate the for-
mation of this N–C6 bond into the synthetic plan. 
Scheme 1. Synthetic Strategy toward the Hetisine Core 
 
Our research group has identified a central fused 6–7–6 tri-
cycle (Scheme 1, highlighted in red) as a key structural motif in 
the core scaffold of these complex alkaloids. This design choice 
arises from a network analysis approach to retrosynthesis,11 in 
which the [2.2.2]bicycle is forged late-stage through a [4+2] cy-
cloaddition reaction on a derivative of vinyl arene 5. Further 
disconnection of the C–N bonds leads both the hetidine and he-
tisine cores back to an all-fused 6–7–6 tricycle (6), the key tar-
get for our collective synthetic strategies. 
 Initial efforts in our group utilized a gallium(III)-catalyzed 
cycloisomerization reaction to convert alkyne 7 into 6–7–6 tri-
cycle 8.7 While this reaction proceeds in a high 89% yield, this 
alkyne takes 13 steps to synthesize (longest linear sequence) 
and the resulting tricycle is relatively unfunctionalized. Several 
steps are then required to introduce key functional groups for 
both the C–N bond forming reactions and the [4+2] cycloaddi-
tion. Despite these challenges, the overall strategy was vali-
dated with the successful synthesis of the hetidine-type core, 
which was further elaborated to dihydronavirine (2, Figure 1), 
the formal hydrogenation product of the natural product 
navirine. 
Scheme 2. Efforts toward the Central 6–7–6 Tricycle 
 
On the basis of this precedent, we embarked on a streamlined 
and higher yielding synthesis of a tricycle that would be more 
ideally functionalized to access the hetisine-type core. We en-
visioned diketoaldehyde 10 as an ideal precursor, with carbonyl 
groups at all three carbon atoms that form C–N bonds in the 
hetisine-type alkaloids (Scheme 3). Intramolecular addition of 
the aromatic ring moiety in 9 was predicted to enable the syn-
thesis of this desired tricycle. We envisioned a rapid synthesis 
of this compound from bicyclic anhydride 11, which could be 
readily accessed through a Diels–Alder cycloaddition from 
diene 12 and dienophile 13. 
Scheme 3. Retrosynthetic Analysis 
 
The synthesis begins with the construction of maleic anhy-
dride dienophile 13 (Scheme 4) following a sequence used to 
synthetize a related compound by Wood and coworkers.12 In 
this route, benzyl protection of commercially available 3-butyn-
1-ol (14) is followed by a palladium-catalyzed dicarboxylation 
reaction to access diester 16 in 65% yield over two steps after 
optimization. Saponification of the diester enabled a dehydra-
tive cyclization reaction in the presence of acetic anhydride to 
give dienophile 13 in 4 steps. Diels–Alder cycloaddition with 
known diene 1213 then affords Diels–Alder adduct 11 in 72% 
yield as a single diastereomer. 
Scheme 4. Dienophile Synthesis and Diels–Alder Cycload-
dition 
 
After exploring a wide range of nucleophiles, we discovered 
benzylic ester 17 (readily synthesized through esterification of 
3-methoxyphenylacetic acid) adds with complete chemoselec-
tivity into the desired carbonyl group. Treatment with HCl then 
cleaves the silyl ether, and the resulting primary hydroxyl group 
spontaneously cyclizes to form lactone acetal 18. A Krapcho-
type decarboxylation with lithium chloride14 facilitates removal 
of the methyl ester after which a one-pot alkene hydrogena-
tion/benzyl ether hydrogenolysis provides primary alcohol 19. 
A Grieco elimination completes the installation of the vinyl 
group needed for eventual formation of the [2.2.2]bicycle, af-
fording 9. This sequence proceeds in only 5 steps and 52% over-
all yield, allowing rapid access to the cyclization precursor. 
Scheme 5. Elaboration to Vinyl Lactone-Acetal 
 
We initially explored using a direct Friedel–Crafts cycliza-
tion to forge the desired C–C bond. Despite screening a variety 
of Lewis acids, cyclization was not observed, with most at-
tempts simply leading to recovery of starting material. We then 
turned to the formation of a discreet aromatic nucleophile via 
metal-halogen exchange of an aryl iodide. An investigation of 
electrophilic iodination conditions, including iodine monochlo-
ride and NIS, with and without Bronsted or Lewis acid addi-
tives, identified an indium(III) triflate-catalyzed protocol devel-
oped by Romo and coworkers as the most effective,15 producing 
the desired aryl iodide (21), along with its ortho-positioned iso-
mer (20), in a roughly 1:1 mixture (Scheme 6). These isomers 
were readily separated, and the undesired isomer could be recy-
 cled through metal-halogen exchange to regenerate vinyl lac-
tone-acetal 9 (see the Supporting Information for details). Ulti-
mately, a 65% yield of desired aryl iodide 21 (based on recov-
ered starting material) could be obtained. 
Scheme 6. Completion of the Desired 6–7–6 Tricycle 
 
With aryl iodide 21 in hand, conditions for metal-halogen ex-
change were then investigated. Lithium-halogen exchange16 
proved to be too reactive, leading only to nonspecific decompo-
sition products. Direct Grignard formation with magnesium 
turnings was likewise unsuccessful, returning only starting ma-
terial. Classic magnesium-halogen exchange17 with iso-propyl 
magnesium chloride or with the Turbo Grignard reagent18 like-
wise proved to be too unreactive to lead to product formation. 
Lithium trialkylmagnesiates, developed by Oshima and 
coworkers,19 gratifyingly facilitated magnesium-halogen ex-
change as well as a subsequent 1,2-addition of the resulting 
magnesiate into the lactone carbonyl. The resulting adduct ex-
ists as an equilibrium of hemiacetal structures; as such, the 
crude reaction mixture was directly oxidized with Dess-Martin 
periodinane following a modified protocol reported by Nico-
laou,20 providing diketoaldehyde 10, the structure of which was 
confirmed by an X-ray crystallographic study of a single crys-
tal. This sequence proceeds in 59% yield over 2 steps and can 
be readily performed on gram-scale, allowing for rapid material 
throughput. 
This route to diketoaldehyde 10 represents the next step in 
our group’s evolving strategy to rapidly access the 6–7–6 fused 
tricyclic core of hetidine- and hetisine-type diterpenoid alkaloid 
natural products. Building upon our previous synthetic studies, 
we have now designed an efficient route to a highly functional-
ized 6–7–6 tricycle. This route features a highly diastereoselec-
tive Diels–Alder cycloaddition, chemoselective addition of a 
benzyl enolate nucleophile, and a finely-tuned magnesiate ad-
dition/ring-expansion/oxidation sequence to access the desired 
tricycle. This tricycle possesses key functional groups at strate-
gic locations, with carbonyl groups at all three carbon atoms 
bearing C–N bonds in the hetisine-type alkaloids, as well as the 
aromatic ring and vinyl group required for the eventual [4+2] 
cycloaddition reaction. Further studies will focus on the selec-
tive derivatization and elaboration of this tricycle into the hetis-
ine-type core, selected natural products, and structural deriva-
tives for biological evaluation. 
The Supporting Information is available free of charge on the ACS 
Publications website. 
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